Darryl McConnel

Title: Darryl McConnel: Innovator in Anti-Proliferative Agents

Introduction

Darryl McConnel is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target excessive cell proliferation. His work is crucial in the fight against various diseases characterized by abnormal cell growth.

Latest Patents

Darryl holds a patent for "Pyrrolobenzimidazolones and their use as anti-proliferative agents." This invention relates to pyrrolobenzimidazolone compounds of formula (I), which are suitable for treating diseases marked by excessive or abnormal cell proliferation. The patent outlines the use of these compounds in preparing pharmaceutical compositions aimed at combating such conditions. He has 1 patent to his name.

Career Highlights

Darryl McConnel is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role at the company allows him to work on innovative solutions that address critical health issues. His expertise in the field has positioned him as a valuable asset to his team and the broader scientific community.

Collaborations

Darryl collaborates with esteemed colleagues, including Steffen Steurer and Bernd Krist. Their combined efforts contribute to advancing research and development in the pharmaceutical sector.

Conclusion

Darryl McConnel's work in developing anti-proliferative agents showcases his commitment to improving healthcare through innovation. His contributions are vital in addressing diseases associated with abnormal cell growth, making a significant impact in the pharmaceutical industry.